国际皮肤性病学杂志    2004 30 (2): 114-116   ISSN: 2096-5540  CN: 32-1880/R   外科手术治疗皮肤黑素瘤的进展 林颖, 李春英, 高天文 第四军医大学西京医院全军皮肤性病中心, 西安 710032 收稿日期 2003-05-12  修回日期 null  网络版发布日期 null 参考文献  [1] Schuchter LM. Review of the 2001 AJCC staging system for cutaneous malignant melanoma. Curr Oncol Rep, 2001, 3(4):332-337. [2] Roses DF, Harris MN, Rigel D, et al. Local and in-transit metastases following definitive excision for primary cutaneous malignant melanoma. Ann Surg, 1983, 198(1):65-69. [3] Moehrle M, Metzger S, Schippert W,et al. "Functional" surgery in subunguai melanoma. Dermatol Surg, 2003, 29(4):366-374. [4] Nagi C, OGrady TC, Izadpanah A. Mohs micrographically controlled surgery and the treatment of malignant melanoma. Semin Oncol,2002, 29(4):336-340. [5] Bienert TN, Trotter M J, Arlette JP. Treatment of cutaneous melanoma of the face by Mohs micrographic surgery. J Cutan Med Surg, 2003, 7(1):25-30. [6] Zitelli JA, Brown CD, Hanusa BH. Surgical margins for excision of primary cutaneous melanoma. J Am Acad Dermatol, 1997, 37(3 Pt 1):422-429. [7] Brown CD, Zitelli JA. The prognosis and treatment of true local cutaneous recurrent malignant melanoma. Dermatol Surg, 1995, 21(4):285-290. [8] McMasters KM, Sondak VK, Lotze MT, et al. Recent advances in melanoma staging and therapy. Ann Surg Oncol, 1999, 6(5):467. [9] Statius Muller MG, Hennipman FA, van Leeuwen PA, et al. Unpredictability of lymphatic drainage patterns in melanoma patients. Eur J Nucl Med Mol Imaging, 2002, 29(2):255-261. [10] Statius Muller MG, van Leeuwen PA, de Lange-De Klerk ES, et al.The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage Ⅰ or Ⅱ cutaneous melanoma.Cancer, 2001, 91(12):2401-2408. [11] Medina-Franco H, Beenken SW, Heslin MJ, et al. Sentinel node biopsy for cutaneous melanoma in the head and neck. Ann Surg Oncol,2001,8(9):716-719. [12] Jansen L, Nieweg OE, Peterse JL, et al. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg, 2000, 87(4):484. [13] Blaheta HJ, Ellwanger U, Schittek B, et al. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol, 2000, 114(4):637-642. [14] van der Velde-Zimmermann D, Schipper ME, de Weger RA, et al.Sentinel node biopsies in melanoma patients:a protocol for accurate,efficient, and cost-effective analysis by preselection for immunohistochemistry on the basis of Tyr-PCR. Ann Surg Oncol, 2000, 7(1):51. [15] Corsetti RL, Allen HM, Wanebo HJ. Thin[16] Uren RF, Howman-Giles R, Thompson JF. Lymphatic drainage from the skin of the back to retroperitoneal and paravertebral lymph nodes in melanoma patients. Ann Surg Oncol, 1998, 5(4):384-387. [17] Karakousis CP, Grigoropoulos P. Sentinel node biopsy before and after wide excision of the primary melanoma. Ann Surg Oncol, 1999, 6(8):785-789. [18] Starz H, Balda BR, Kramer KU, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer, 2001, 91(11):2110-2121. [19] Sheridan AT, Dawber RP. Curettage, electrosurgery and skin cancer.Australas J Dermatol, 2000, 41(1):19-30. [20] Goldman G. The current status of curettage and electrodesiccation.Dermatol Clin, 2002, 20(3):569-578. [21] Kuflik EG, Gage AA. Cryosurgery for lentigo maligna. J Am Acad Dermatol, 1994, 31(1):75-78. [22] Mir LM, Rubinsky B. Treatment of cancer with cryochemotherapy. Br J Cancer, 2002, 86(10):1658-1660. 通讯作者: